Anti-diabetic treatment regulates pro-fibrotic TGF-β serum levels in type 2 diabetics.

First published in Diabetology & Metabolic Syndrome on 2013 Aug.
Diabetol Metab Syndr. 2013 Aug 31;5(1):48. doi: 10.1186/1758-5996-5-48.

Authors: Pscherer S, Freude T, Forst T, Nussler AK, Braun KF, Ehnert S

 

 

 

 

Read more

Download full article as Pdf file:

Pdf File

 

REACHING OUT IS EASY AND FAST – LET’S TALK

Dr. Marc Hetzel

VP & Head of Business Development
located at CRS Management


LET’S TALK BUSINESS